$251 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 13 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 18.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | Buy | KARUNA THERAPEUTICS INC | $134,766,083 | -20.5% | 797,008 | +1.9% | 53.75% | -3.8% |
| PCVX | VAXCYTE INC | $40,429,128 | +2.1% | 793,036 | 0.0% | 16.12% | +23.5% | |
| Sell | OCULIS HOLDING AGordinary shares | $24,406,294 | -16.9% | 2,218,754 | -6.8% | 9.74% | +0.6% | |
| INZY | Buy | INOZYME PHARMA INC | $18,878,374 | -7.4% | 4,494,851 | +22.8% | 7.53% | +12.0% |
| RALLYBIO CORP | $8,103,650 | -40.5% | 2,404,644 | 0.0% | 3.23% | -28.0% | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $5,869,191 | -44.3% | 1,105,309 | 0.0% | 2.34% | -32.6% | |
| FUSN | FUSION PHARMACEUTICALS INC | $4,058,553 | -44.3% | 1,560,982 | 0.0% | 1.62% | -32.6% | |
| GRCL | New | GRACELL BIOTECHNOLOGIES INCsponsored ads | $3,960,000 | – | 1,375,000 | +100.0% | 1.58% | – |
| EXSCIENTIA PLCads | $3,482,660 | -23.6% | 770,500 | 0.0% | 1.39% | -7.6% | ||
| VIGIL NEUROSCIENCE INC | $3,021,607 | -42.7% | 560,595 | 0.0% | 1.20% | -30.6% | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,967,126 | -18.7% | 1,891,467 | 0.0% | 0.78% | -1.6% | |
| New | IO BIOTECH INC | $1,218,518 | – | 864,197 | +100.0% | 0.49% | – | |
| ALGS | ALIGOS THERAPEUTICS INC | $555,182 | -23.1% | 743,215 | 0.0% | 0.22% | -7.1% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
| VAXCYTE INC | 12 | Q3 2023 | 19.5% |
| INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
| ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
| FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
| ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
| BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
| RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
| AKOUOS INC | 8 | Q3 2022 | 11.7% |
| EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.